Medicare Enrolled

Dr. Melissa Herbein, CRNP

Physician Assistant · Wyomissing, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1320 BROADCASTING RD STE 200, Wyomissing, PA 19610
6103728995
In practice since 2018 (7 years)
NPI: 1225506298 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Herbein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Herbein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Herbein

Dr. Melissa Herbein is a physician assistant in Wyomissing, PA, with 7 years of NPI registration. Based on federal Medicare data, Dr. Herbein performed 10,873 Medicare services across 2,401 unique beneficiaries.

Between the years covered by Open Payments, Dr. Herbein received a total of $2,773 from 27 pharmaceutical and/or device companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Herbein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice ▲ Top 0% volume in PA $2,773 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,873
Medicare services
Top 0% in PA for physician assistant
2,401
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,553 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
BCG treatment for bladder cancer 4,753 $2 $5
Infectious disease DNA/RNA test
A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism.
2,041 $34 $53
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
925 $3 $12
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
801 $73 $267
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
534 $7 $146
Nucleic acid test for multiple organisms
A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample.
471 $68 $105
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
257 $51 $184
VRE nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample.
156 $34 $53
Staphylococcus aureus DNA test
A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample.
156 $34 $53
MRSA nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
156 $34 $53
Leuprolide acetate (for depot suspension), 7.5 mg 141 $135 $650
Simple change of bladder tube 111 $59 $238
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
106 $54 $220
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
69 $35 $162
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
57 $8 $50
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
56 $94 $406
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
36 $20 $85
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
32 $6 $175
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $34 $111
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,773
Total received (2021-2024)
Avg $693/year across 4 years
Top 11% in PA for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
103
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,371 (85.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$401 (14.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$312
2023
$492
2022
$831
2021
$1,138

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$94
Tolmar, Inc.
$68
UROGEN PHARMA, INC.
$47
COLOPLAST CORP
$41
DENTSPLY IH AB
$32
Tempus AI, Inc
$30
Top 3 companies account for 67.1% of 2024 payments
All-time payments by company (2021-2024) ›
CIPLA USA INC.
$794
Astellas Pharma US Inc
$497
Janssen Biotech, Inc.
$245
Sumitomo Pharma America, Inc.
$205
UROVANT SCIENCES INC
$144
UroGen Pharma, Inc.
$120
Tolmar, Inc.
$68
DENTSPLY IH Inc.
$65
Axonics, Inc.
$61
Bayer HealthCare Pharmaceuticals Inc.
$54
ConvaTec Inc.
$52
UROGEN PHARMA, INC.
$47
Medtronic, Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$44
COLOPLAST CORP
$41
AstraZeneca Pharmaceuticals LP
$37
Blue Earth Diagnostics Limited
$34
Novartis Pharmaceuticals Corporation
$33
DENTSPLY IH AB
$32
Tempus AI, Inc
$30
Coloplast Corp
$28
180 Medical, Inc.
$22
Accord Healthcare, Inc.
$18
Clarus Therapeutics Inc.
$18
Foundation Medicine, Inc.
$14
Amgen Inc.
$13
Myovant Sciences Inc.
$12
Top 3 companies account for 55.4% of all-time payments
Associated products mentioned in payments ›
Axonics · Axonics r-SNM System · Axumin · CAMCEVI · ELIGARD · ERLEADA · GEMTESA · GENTLECATH · INTERSTIM · JATENZO · JELMYTO · LOFRIC · LYNPARZA · LoFric · Luja Coude · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · PLUVICTO · SpeediCath · XGEVA · XTANDI · Xtandi · ZEMDRI (PLAZOMICIN)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a physician assistant in Wyomissing?
Compare physician assistants in the Wyomissing area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants within 10 mi
145
Per 100K population
33.7
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Herbein is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 11% of PA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Herbein experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Herbein performed 4,753 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Herbein receive payments from pharmaceutical companies?
Yes. Dr. Herbein received a total of $2,773 from 27 companies across 103 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Herbein's costs compare to other physician assistants in Wyomissing?
Dr. Herbein's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Herbein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →